11:15 AM EDT, 11/01/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were rallying late Friday morning, rising 0.98% to 1,367.20 on the S&P Europe Select ADR Index, but were still down 1.4% for the week.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and semiconductor company Sequans Communications ( SQNS ) , which rose 5.8% and 3.3%, respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria ( BBVA ) , which were up 2.4% and 2.1%, respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm BioNTech (BNTX), which fell 4.7% and 1.4%, respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and internet advertising firm Criteo ( CRTO ) , which were off 0.8% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which increased 5.4% and 3.6%, respectively. They were followed by financial services company Lloyds Banking Group ( LYG ) and biopharmaceutical company Amarin Corporation ( AMRN ) , which rose 2.9% and 2.8%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) , which fell 3.4%, followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and cruise line operator Carnival (CUK) were off 0.2% and 0.1%, respectively.